Nureca Limited (NURECA) Financial Results — Revenue ₹40.3

Revenue: ₹40.3Net Profit: ₹3.1

📢 Key Event
Nureca reports Q1 FY27 revenue of ₹40.3 crores, up 14% QoQ and 18% YoY.

🔄 What Changed
Operating profit margin improved to 8.7% from 7.3% QoQ; PAT rose to ₹3.1 crores from ₹0.9 crores YoY.

🔮 What's Next
The company projects market growth to ₹5,203 crores by 2030 at 9.9% CAGR and plans to expand manufacturing capacity in Punjab for medical devices and consumables.

💡 Investor Takeaway
Nureca is achieving profitable growth through its integrated healthcare platform and manufacturing expansion, with strong margins and rising profitability.

Nureca reported Q1 FY27 revenue of ₹40.3 crores, up 14% QoQ and 18% YoY, driven by strong gross margins and operating profitability. The company posted a PAT of ₹3.1 crores, reflecting significant improvement from prior periods. This performance marks the strongest quarterly results in 16 quarters, underscoring progress in its consumer healthcare platform strategy.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NURECA ✨ Ask AI About This